The DKA playbook: Applying Guidelines to Real-World Diagnosis
Released On
July 8, 2025
Expires On
July 8, 2026
Media Type
Internet
Completion Time
15 minutes
Specialty
Diabetology, Endocrinology, Primary Care
Topics
Diabetes, Diabetic Ketoacidosis
Other modules in the Ketone Masterclass series
- Access: Pathways to Prevention: Understanding the Mechanisms Driving DKA
- Access: Beyond the Strip: Innovations in Ketone Monitoring and Clinical Applications
- Access: The Ketone Conversation: Removing Barriers and Rethinking Monitoring
Acknowledgement
This activity is supported by an independent educational grant from Abbott.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in ketone monitoring technology for patients with T2D.
Program Overview
Welcome to this Ketone Masterclass Module, which is a part of the larger CME-accredited program, Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management.
Developed by Dr. Jennifer Sherr, MD, PhD, this masterclass explores the latest guidelines, clinical data and evidence-based diagnostic criteria for assessing diabetic ketoacidosis (DKA) in patients with diabetes.
*Featuring a real-world diagnostic case study
*Ready-to-use in the clinic: download the quick reference practice aid, summarizing this masterclass
---
This activity is part of the larger CME-accredited program Integrating Ketone and Glucose Monitoring for Optimized Diabetes Management. Register for free to continue your Ketone Monitoring Masterclass journey or tune into conference highlights with program Director Dr. David Kerr. MBChB, DM, FRCP, FRCPE. © 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify the most recent guidelines and definitions of DKA.
Faculty
Jennifer L. Sherr, MD, PhD
Professor of Pediatrics
CT, United States
Dr Jennifer L. Sherr was determined to become a pediatric endocrinologist since the time of her diagnosis with T1D in 1987. While she always wanted to care for those with T1D, her eyes were opened to the meaningful impact that clinical research has. Dr Sherr has been devoted to clinical research for more than 15 years. She serves as the Medical Director of Pediatric Diabetes and Professor in the Department of Pediatrics at Yale and focuses on methods to improve the lives of all people living with diabetes, including new technologies and therapeutics.
Joint Accreditation Statement
In support of improving patient care, this program has been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosure of Conflicts of Interest
Dr. Jennifer Sherr:
- Grant/research support: Abbott Diabetes, Dexcom, Insulet, JDRF/Breakthrough T1D, Medtronic, NIG, Provention Bio
- Consultant/advisory board: Abbott Diabetes, Cecelia Health, Insulet, Mannkind, Medscape, Medtronic Diabetes, StartUp Health T1D Moonshot, Vertex, Ypsomed
Dr Sherr’s contribution to this program was done in her individual capacity and not in connection with her Yale University duties or responsibilities.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Complete the pre-test.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes for healthcare professionals only. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]